Capital World Investors
NVCR icon

Capital World Investors’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$114M Buy
6,382,848
+1,167,319
+22% +$20.8M 0.02% 336
2025
Q1
$92.9M Buy
5,215,529
+400,000
+8% +$7.13M 0.02% 345
2024
Q4
$144M Buy
4,815,529
+507,311
+12% +$15.1M 0.02% 306
2024
Q3
$67.3M Buy
4,308,218
+2,000,003
+87% +$31.3M 0.01% 374
2024
Q2
$39.5M Hold
2,308,215
0.01% 401
2024
Q1
$36.1M Sell
2,308,215
-968,781
-30% -$15.1M 0.01% 420
2023
Q4
$48.9M Sell
3,276,996
-5,601,735
-63% -$83.6M 0.01% 384
2023
Q3
$143M Sell
8,878,731
-2,511,814
-22% -$40.6M 0.03% 296
2023
Q2
$473M Sell
11,390,545
-2,634,512
-19% -$109M 0.09% 199
2023
Q1
$843M Buy
14,025,057
+1,175,538
+9% +$70.7M 0.17% 138
2022
Q4
$943M Buy
12,849,519
+61,280
+0.5% +$4.49M 0.2% 122
2022
Q3
$972M Buy
12,788,239
+1,065,755
+9% +$81M 0.22% 112
2022
Q2
$815M Sell
11,722,484
-928,159
-7% -$64.5M 0.17% 135
2022
Q1
$1.05B Buy
12,650,643
+26,600
+0.2% +$2.2M 0.18% 129
2021
Q4
$948M Buy
12,624,043
+3,543
+0% +$266K 0.15% 147
2021
Q3
$1.47B Buy
12,620,500
+774,799
+7% +$90M 0.25% 92
2021
Q2
$2.63B Buy
11,845,701
+3,208,178
+37% +$712M 0.45% 54
2021
Q1
$1.14B Buy
8,637,523
+892,485
+12% +$118M 0.21% 119
2020
Q4
$1.34B Buy
7,745,038
+1,115,021
+17% +$193M 0.26% 96
2020
Q3
$738M Buy
6,630,017
+1,326,769
+25% +$148M 0.16% 134
2020
Q2
$314M Buy
5,303,248
+367,900
+7% +$21.8M 0.08% 210
2020
Q1
$332M Sell
4,935,348
-99,972
-2% -$6.73M 0.1% 179
2019
Q4
$424M Buy
5,035,320
+491
+0% +$41.4K 0.09% 193
2019
Q3
$377M Sell
5,034,829
-199,983
-4% -$15M 0.09% 192
2019
Q2
$331M Buy
5,234,812
+200,415
+4% +$12.7M 0.08% 202
2019
Q1
$243M Buy
5,034,397
+2,240,586
+80% +$108M 0.06% 225
2018
Q4
$93.5M Buy
2,793,811
+528,500
+23% +$17.7M 0.03% 291
2018
Q3
$119M Buy
2,265,311
+386,600
+21% +$20.3M 0.03% 292
2018
Q2
$58.8M Buy
+1,878,711
New +$58.8M 0.01% 354